A Double-Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) versus Oral Oxybutynin in SCI Patients with NDO (11-09-10-04)
Abstract
No subjects have been treated as yet. Recruitment at Michael E. DeBakey VAMC has been difficult due to eligibility criteria.Dr. Smith plans to open patient recruitment to a new site with a large spinal cord injury population, The Institute of Rehabilitation and Research (TIRR). The BCM IRB initial approval of the addition of the TIRR Memorial Hermann site has been approved. The application to the Memorial Hermann Office of Research has been submitted and approval is awaiting final budget agreement. Once the study has been approved by Memorial Hermann, the HPRO will be notified. Recruitment will begin after HPRO approval is received.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2015
- Accession Number
- AD1005804
Entities
People
- Christopher P. Smith
Organizations
- Baylor College of Medicine